Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$13.10 USD
-1.50 (-10.27%)
Updated May 7, 2024 04:00 PM ET
After-Market: $13.08 -0.02 (-0.15%) 7:36 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.20 | 0.00% |
Earnings Summary
For their last quarter, Enanta Pharmaceuticals (ENTA) reported earnings of -$1.47 per share, missing the Zacks Consensus Estimate of -$1.26 per share. This reflects a negative earnings surprise of 16.67%. Look out for ENTA's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.20 per share, reflecting a year-over-year increase of 35.48%.
Earnings History
Price & Consensus
Zacks News for ENTA
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
ENTA: What are Zacks experts saying now?
Zacks Private Portfolio Services